IGF2BP2 and cervical carcinoma: Hu et al. [172] initiated their study with HPV and discovered that silencing the E6/E7 genes leads to a reduction in the expression of IGF2BP2, consequently weakening the aerobic glycolysis capacity and growth of cervical cancer cells.